Investor Resources

Quick Explore

icon-pdf
Reappointment of Ms. Samina Hamied and Ms. Naina Lal Kidwai
15th May 2020
icon-pdf
Press release - Cipla enters into a licensing agreement with Gilead to expand access to COVID-19 treatment
13th May 2020
icon-pdf
Earnings Conference call – May 2020
12th May 2020
icon-pdf
Notice of Board Meeting – May 2020
09th May 2020
icon-pdf
Receipt of Establishment Inspection Report
08th May 2020
icon-pdf
Press Release - Cipla stands strong with India in the battle against COVID-19
21st Apr 2020
icon-pdf
Allotment of 3,910 equity shares under ESOS
13th Apr 2020
icon-pdf
Intimation regarding payment status of Interim Dividend 2019-20
09th Apr 2020
icon-pdf
Press Release - Cipla receives final approval for generic version of Proventil® HFA Inhalation Aerosol (Albuterol Sulfate Inhalation Aerosol 90mcg (base)/actuation)
09th Apr 2020
icon-pdf
Press Release - Successful completion of Phase-3 clinical study for generic version of GSK’s Advair Diskus®
02nd Apr 2020
 
BSE and NSE Quotes by TradingView

The displayed data is not in real time and may have streaming delays.